This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Short stature, not elsewhere classified
E4_SHORT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
894 |
4. Check minimum number of eventsNone |
894 |
5. Include endpointsNone |
894 |
6. Filter based on genotype QC (FinnGen only) |
894 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Short stature, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other endocrine disorders
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 894 | 509 | 385 |
| Unadjusted period prevalence (%) | 0.17 | 0.17 | 0.17 |
| Median age at first event (years) | 8.55 | 9.38 | 7.46 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 763
- Matched controls
- 7281
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E34.35
ICD-10 Finland
Abnormal growth retardation
2214.8
323.0
421
*
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
1777.5
270.8
251
*
H01AC01
ATC
somatropin; parenteral
1093.0
253.7
238
*
E34.30
ICD-10 Finland
Short stature NOS
+∞
212.6
197
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
25.5
194.3
287
168
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
149.7
141
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
137.6
130
*
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
1133.0
106.2
103
*
301
Kela drug reimbursment
Growth hormone
351.8
95.6
96
*
E34.31
ICD-10 Finland
Short stature, prenatal disorder
873.8
83.8
82
*
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
+∞
56.0
54
*
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
18.7
49.6
78
44
E34.3
ICD-10 Finland
Short stature, not elsewhere classified
+∞
44.5
43
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.0
39.1
179
517
E30.09
ICD-10 Finland
Delayed puberty NOS
+∞
36.1
35
*
E30.00
ICD-10 Finland
Familial delayed puberty
+∞
35.1
34
*
602
Kela drug reimbursment
Children's severe malnutrition
6.3
29.2
81
134
Z3226
NOMESCO Finland
Physiotherapist
2.5
22.8
230
1086
BF20A
NOMESCO Finland
NA
+∞
22.6
22
*
Z31.5
ICD-10 Finland
Genetic counselling
3.6
22.1
108
320
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
18.2
225
1157
Z3231
NOMESCO Finland
Registered nurse
2.0
17.4
304
1802
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
30.8
16.7
22
7
R62.0
ICD-10 Finland
Delayed milestone
3.4
16.7
84
254
E22.80
ICD-10 Finland
Central precocious puberty
165.7
16.2
17
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.5
15.6
56
125
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
15.4
15
*
E34.45
ICD-10 Finland
Abnormal growth increase
82.9
15.3
17
*
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
155.8
15.2
16
*
RD210
NOMESCO Finland
NA
3.3
14.5
77
242
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.2
14.2
163
799
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
13.7
101
394
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
13.2
158
786
H02AB09
ATC
hydrocortisone; systemic
3.5
13.1
61
174
ZXE00
NOMESCO Finland
One hour or less
1.8
13.0
322
2100
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
12.8
278
1732
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.4
12.8
46
104
L02AE02
ATC
leuprorelin; implant, parenteral
12.7
12.6
22
17
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
11.3
12.5
23
20
E30.9
ICD-10 Finland
Disorder of puberty, unspecified
+∞
12.3
12
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
12.2
142
694
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
11.9
223
1316
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
11.8
160
838
127
Kela drug reimbursment
Transplant complication
5.2
11.7
36
69
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
29.2
11.4
15
5
Z2221
NOMESCO Finland
Medical doctor
1.8
11.1
218
1301
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
10.8
45
117
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.6
10.7
48
133
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
10.4
81
325
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.5
10.3
26
39
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
10.3
208
1247
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
10.3
77
300
2594A
ICD-9 Finland
Other endocrine disorders, Dwarfism, not elsewhere classified
+∞
10.3
10
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.9
10.1
63
222
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
10.0
142
751
R4110
NOMESCO Finland
Physiotherapy
1.8
9.9
190
1119
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.8
9.8
62
221
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
9.8
9.7
19
19
XA800
NOMESCO Finland
Neuropsychological investigation
2.4
9.7
83
351
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
3.0
9.7
55
182
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
4.1
9.7
37
90
Z2445
NOMESCO Finland
Psychologist
2.1
9.6
116
573
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
9.6
124
631
L04AA06
ATC
mycophenolic acid; systemic
5.4
9.6
28
51
E30.1
ICD-10 Finland
Precocious puberty
96.6
9.3
10
*
E34.40
ICD-10 Finland
Constitutional tall stature
+∞
9.2
9
*
L04AA01
ATC
[U] ciclosporin; systemic
8.4
9.0
19
22
P05.1
ICD-10 Finland
Small for gestational age
6.3
8.9
23
36
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
8.9
60
223
ZXD05
NOMESCO Finland
Urgent procedure
1.8
8.8
193
1180
121
Kela drug reimbursment
Severe hypofunction of sexual glands
15.1
8.8
14
9
F83
ICD-10 Finland
Mixed specific developmental disorders
2.8
8.7
58
211
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.4
8.7
72
299
K03.66
ICD-10 Finland
Tooth plaque
2.0
8.6
115
592
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
8.5
218
1395
A11CC03
ATC
alfacalcidol; systemic
4.8
8.5
27
55
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.6
8.5
60
228
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
8.2
8
*
RL140
NOMESCO Finland
NA
4.4
8.1
28
62
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
8.3
8.1
17
20
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
4.7
8.1
26
54
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
7.9
74
326
ZXA05
NOMESCO Finland
Left side
2.1
7.9
90
435
R4190
NOMESCO Finland
Nutritional therapy
2.0
7.8
105
544
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.0
7.6
29
71
ZXA10
NOMESCO Finland
Bilateral
1.9
7.6
123
678
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
7.5
113
608
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
7.4
94
473
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.1
7.3
39
126
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
7.3
135
780
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.8
7.2
43
150
BC00A
NOMESCO Finland
NA
9.1
7.1
14
15
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.0
110
600
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
7.0
68
307
TJD20
NOMESCO Finland
Change of gastrostomy tube
5.0
7.0
21
41
G03FB08
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
19.3
7.0
10
5
T10
ICPC
Growth delay
5.6
7.0
19
33
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
6.7
91
471
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.5
6.7
352
2654
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
6.7
31
91
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.6
6.6
46
174
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
38.5
6.6
8
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
10.6
6.6
12
11
N91.0
ICD-10 Finland
Primary amenorrhoea
16.1
6.6
10
6
Z2446
NOMESCO Finland
Social worker
1.7
6.6
137
820
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.7
6.6
27
72
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
6.5
38
130
Q87.14
ICD-10 Finland
Noonan's syndrome
21.7
6.5
9
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.5
122
706
L04AD01
ATC
ciclosporin; systemic
3.5
6.5
28
78
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
4.6
6.4
21
45
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
6.4
85
437
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.9
6.3
24
60
H03AA01
ATC
levothyroxine sodium; systemic
2.0
6.2
76
379
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
+∞
6.1
6
*
102
Kela drug reimbursment
Diabetes insipidus
+∞
6.1
6
*
E28.3
ICD-10 Finland
Primary ovarian failure
+∞
6.1
6
*
137
Kela drug reimbursment
Uraemia requiring dialysis
6.3
6.1
15
23
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.8
6.1
16
27
H52.0
ICD-10 Finland
Hypermetropia
2.5
6.0
43
167
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
144
21
76.41
251.82
6.4
3.2
ug/l
2.0
3.1
1.05
144
21
(3035637) Corticotropin [Mass/volume] in Plasma
122
167
7.77
79.35
1.6
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
226
675
3.86
60.14
2.7
2.5
nmol/l
320.2
350.4
1.57
220
639
(3023323) Follitropin [Units/volume] in Serum or Plasma
159
379
4.57
57.16
2.6
1.7
iu/l
6.8
6.9
0.02
114
247
(3003458) Phosphate [Moles/volume] in Serum or Plasma
304
1134
3.29
57.00
12.7
11.3
mmol/l
1.3
1.3
0.19
284
1092
(3009214) Lutropin [Units/volume] in Serum or Plasma
164
413
4.33
54.84
2.6
1.7
u/l
3.9
5.9
3.62
110
266
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
62
83
7.44
40.62
2.3
1.9
nmol/l
0.1
0.2
0.92
49
62
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
712
4800
2.94
37.46
4.7
3.5
pmol/l
14.3
14.4
0.14
685
4389
(40765089) Chromosome analysis panel - Blood by G-banded
57
77
7.34
37.02
1.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
545
3391
2.30
31.12
4.0
3.0
mmol/mol
33.9
36.3
10.48
530
3195
(3015377) Calcium [Moles/volume] in Serum or Plasma
279
1306
2.46
31.09
3.2
2.7
mmol/l
2.4
2.4
1.21
258
1183
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
548
3443
2.28
30.18
7.8
5.4
u/l
129.3
112.8
4.35
517
3228
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
49
77
6.25
27.62
2.0
1.9
ng/l
153.1
130.7
0.91
49
71
(3017446) Testosterone [Moles/volume] in Serum or Plasma
115
357
3.32
27.59
2.8
1.9
nmol/l
9.1
11.3
1.55
92
288
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
746
5488
2.69
26.70
5.0
3.9
mu/l
1.9
1.9
0.35
727
5167
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
393
2432
1.92
19.34
5.2
3.1
nmol/l
73.3
68.3
3.33
379
2312
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
427
2722
1.90
19.13
1.6
1.8
u/ml
1.1
3.3
2.74
52
518
(3007164) IgA [Mass/volume] in Serum or Plasma
409
2574
1.90
19.03
2.0
1.6
g/l
1.5
1.6
1.57
177
1366
(40758558) Short blood count panel - Blood
359
2166
1.93
18.98
11.6
8.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
525
3628
1.87
17.76
11.9
9.1
%
0.6
0.6
0.25
512
3476
(3006504) Eosinophils/100 leukocytes in Blood
535
3722
1.87
17.69
11.9
9.0
%
3.5
3.1
1.90
523
3551
(3018418) pH of Serum or Plasma
217
1121
2.07
17.68
5.7
3.4
ph
7.4
7.4
0.29
30
182
(3019069) Monocytes/100 leukocytes in Blood
537
3752
1.86
17.37
12.1
9.1
%
8.3
8.1
0.73
526
3592
(3013650) Neutrophils [#/volume] in Blood by Automated count
580
4164
1.87
17.07
14.7
10.6
e9/l
3.4
3.6
1.14
509
3488
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
49
120
3.99
16.59
4.9
5.1
umol/l
22.8
24.9
0.70
49
120
(3013115) Eosinophils [#/volume] in Blood
554
3944
1.84
16.46
13.0
9.7
e9/l
0.2
0.2
1.23
490
3379
(3001604) Monocytes [#/volume] in Blood
541
3827
1.83
16.38
11.6
8.9
e9/l
0.6
0.6
0.70
472
3206
(36660697) Celiac disease serology panel - Serum
214
1131
2.02
16.22
1.3
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
540
3829
1.82
16.09
11.6
8.9
e9/l
0.0
0.0
0.78
469
3208
(3018010) Neutrophils/100 leukocytes in Blood
545
3896
1.80
15.57
11.5
8.6
%
47.8
50.3
4.07
531
3743
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
99
389
2.56
15.26
2.6
3.5
pmol/l
4.9
5.0
0.34
92
349
(3002030) Lymphocytes/100 leukocytes in Blood
549
3966
1.77
14.77
11.8
8.7
%
37.0
34.8
3.87
534
3803
(42870588) Differential panel, method unspecified - Blood
426
2867
1.75
14.67
12.8
9.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
418
2804
1.75
14.51
18.4
11.2
mmol/l
1.2
1.2
0.45
381
2580
(3013707) Erythrocyte sedimentation rate by Westergren method
561
4092
1.77
14.44
5.6
4.1
mm/h
7.5
7.2
0.38
527
3816
(3019198) Lymphocytes [#/volume] in Blood
550
4001
1.75
14.16
11.5
8.7
e9/l
2.5
2.3
2.19
485
3464
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
151
735
2.11
14.14
4.2
2.9
%
20.0
22.7
1.78
141
690
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
401
2684
1.73
13.82
20.5
12.3
mmol/l
1.2
1.2
0.94
382
2553
(3024561) Albumin [Mass/volume] in Serum or Plasma
299
1843
1.78
13.76
10.5
7.7
g/l
38.5
38.0
0.91
279
1745
(3021589) Normoblasts [#/volume] in Blood
509
3650
1.71
13.52
13.4
10.5
e9/l
0.0
0.0
0.10
399
2807
(3004789) Transferrin [Mass/volume] in Serum or Plasma
157
794
2.03
13.22
4.1
2.8
g/l
2.6
2.6
0.03
150
747
(3022948) Iron [Moles/volume] in Serum or Plasma
168
886
1.96
12.52
4.1
2.8
umol/l
13.1
14.2
1.15
162
845
(3000570) Elastase.pancreatic [Mass/mass] in Stool
48
145
3.22
11.95
1.4
1.3
ug/g
380.5
386.9
0.07
31
64
(3013336) Amino acids [Identifier] in Serum or Plasma
31
73
4.08
11.09
2.5
2.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
221
1343
1.72
10.21
14.8
9.7
mmol/l
0.9
1.2
0.57
165
1061
(3000991) Gas panel - Venous blood
205
1223
1.74
10.11
15.0
10.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
259
1669
1.64
9.49
3.3
3.0
mg/l
2.7
2.5
1.03
235
1475
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
14
9
14.77
8.71
2.7
2.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
21
44
4.55
8.70
1.5
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
53
203
2.54
8.62
16.1
9.8
iu/ml
378.3
375.9
0.00
12
27
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
747
6242
1.75
8.54
11.9
8.3
u/l
23.9
25.5
1.56
726
6014
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
58
248
2.27
7.44
1.7
1.4
ug/l
11.6
4.4
1.19
53
237
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
18
38
4.51
7.40
1.8
2.2
mg/l
3.3
4.0
0.24
13
30
(44790048)
44
169
2.51
7.15
2.6
2.3
—
—
—
0
0
(44806118)
44
169
2.51
7.15
2.6
2.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
89
459
1.91
6.97
2.1
1.9
mmol/l
2.4
2.4
0.49
70
374
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
183
2.43
6.95
5.3
3.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
457
3505
1.45
6.91
4.3
3.1
ug/l
57.8
54.8
0.19
434
3310
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
21
53
3.78
6.89
1.4
2.0
nmol/l
20.3
19.5
—
8
19
(3026493) Urate [Moles/volume] in Serum or Plasma
123
708
1.73
6.73
5.0
4.9
umol/l
5306.2
2202.9
0.40
114
665
(44790047)
43
169
2.45
6.67
2.6
2.3
—
—
—
0
0
(44790049)
43
169
2.45
6.67
2.6
2.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
135
803
1.68
6.55
8.3
6.5
%
1.4
1.4
0.03
126
768
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
20
51
3.73
6.48
5.8
6.9
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
20
51
3.73
6.48
5.8
7.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
763
6534
1.66
6.40
21.7
14.1
%
13.2
13.1
1.57
755
6417
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
52
227
2.22
6.38
2.9
2.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
57
3.51
6.23
8.5
8.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
41
163
2.42
6.22
2.3
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
51
226
2.18
6.05
3.0
2.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
46
196
2.26
5.99
5.2
3.3
e9/l
1.7
1.5
0.51
38
130
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
41
3.94
5.94
8.2
7.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
59
3.39
5.93
1.7
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
784
6800
1.67
5.74
12.2
7.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
44
188
2.25
5.70
5.3
3.3
%
8.5
9.7
0.53
39
174
(1175426) CD3 cells/100 lymphocytes in Blood
44
188
2.25
5.70
5.4
3.3
%
73.7
65.8
2.11
44
188
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
37
147
2.42
5.64
1.9
1.4
nmol/l
0.3
0.4
1.00
31
123
(3042733) HLA Ab [Presence] in Serum
19
52
3.47
5.59
4.1
3.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
97
555
1.71
5.42
5.2
4.9
e9/l
58.5
61.8
0.44
64
339
(3048689) Calprotectin [Mass/mass] in Stool
202
1375
1.49
5.42
3.1
3.2
ug/g
76.3
98.4
0.93
157
1102
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
99
2.70
5.40
2.2
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
33
128
2.47
5.31
1.8
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
32
4.15
5.24
1.4
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
132
826
1.58
5.20
1.2
1.4
—
162.8
—
0
34
(3026782) Osmolality of Urine
195
1329
1.48
5.18
4.5
2.9
mosm/kgh2o
569.7
595.0
0.65
173
1138
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
27
96
2.68
5.16
2.0
2.0
—
—
—
0
0
(3036489) Thrombin time
83
461
1.76
5.15
7.2
7.4
s
22.4
23.2
0.99
78
440
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
71
2.95
5.01
2.8
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
129
810
1.57
5.01
1.9
1.4
u/ml
388.9
298.7
0.45
121
766
(3023103) Potassium [Moles/volume] in Serum or Plasma
689
5862
1.45
4.94
20.0
11.1
mmol/l
3.9
3.9
0.87
665
5626
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
42
188
2.15
4.90
5.2
3.3
e9/l
0.2
0.2
0.32
36
136
(3007461) Platelets [#/volume] in Blood
860
7724
2.26
4.84
23.8
15.1
e9/l
275.2
268.8
1.97
840
7398
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
42
190
2.12
4.78
5.3
3.3
e6/l
715.7
534.4
1.19
36
137
(3000492) Spirometry study
88
510
1.68
4.71
1.8
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
291
2169
1.38
4.65
10.5
7.5
umol/l
15.5
20.3
1.39
268
1975
(3026361) Erythrocytes [#/volume] in Blood
860
7734
2.22
4.64
23.8
15.0
e12/l
4.6
4.6
2.54
839
7387
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
40
3.55
4.59
2.2
3.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
181
2.12
4.56
2.6
2.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
16
45
3.37
4.54
1.3
1.4
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
39
175
2.14
4.54
5.5
3.3
%
29.5
25.0
1.45
39
175
(3010813) Leukocytes [#/volume] in Blood
860
7740
2.20
4.52
23.9
15.1
e9/l
6.9
7.0
0.28
840
7398
(3016244) Insulin [Units/volume] in Serum or Plasma
50
247
1.95
4.50
3.3
3.3
mu/l
10.9
23.7
3.21
50
236
(3019550) Sodium [Moles/volume] in Serum or Plasma
686
5866
1.41
4.47
19.8
11.1
mmol/l
139.3
139.3
0.04
668
5657
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
16
46
3.30
4.40
1.7
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
36
159
2.17
4.37
2.3
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
35
154
2.17
4.29
2.5
1.5
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
10
21
4.50
4.14
1.0
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
116
744
1.53
4.10
1.2
1.2
—
70.8
—
0
5
(3000850) Epithelial cells [#/volume] in Urine
193
1369
1.41
4.07
4.6
2.8
e6/l
8.0
7.1
0.31
172
1186
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
39
3.40
4.04
3.4
2.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
86
518
1.61
3.98
5.3
7.4
ng/l
614.1
1297.6
1.21
79
421
(4035726)
55
293
1.81
3.97
2.4
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
173
2.05
3.91
2.2
3.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
425
3419
1.31
3.90
10.2
7.1
mmol/l
5.8
6.0
1.88
396
3084
(3000060) B lymphocytes [#/volume] in Blood
38
180
2.02
3.88
5.9
3.4
e6/l
320.7
403.2
0.43
30
117
(4062490)
29
124
2.23
3.83
1.5
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
21
78
2.56
3.75
5.7
5.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
171
1206
1.41
3.71
4.7
3.4
e6/l
2.9
2.4
0.27
103
683
(3002582) Erythrocytes [#/volume] in Urine
272
2067
1.33
3.69
5.9
3.8
e6/l
13.6
44.6
1.49
217
1547
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
23
91
2.40
3.62
7.2
11.3
mg/l
9.6
9.1
0.14
23
83
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
31
140
2.11
3.60
1.4
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
285
2189
1.32
3.57
6.2
4.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
183
1317
1.38
3.51
1.9
1.5
pmol/l
96.7
97.8
0.14
99
726
(3026008) Bacteria identified in Urine by Culture
212
1564
1.35
3.48
2.8
2.2
—
—
—
0
0
(4010399)
54
299
1.74
3.45
1.8
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
32
150
2.03
3.39
2.8
2.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
39
3.15
3.37
4.2
3.3
u/ml
875.4
1296.8
0.72
13
39
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
167
1192
1.38
3.36
4.9
3.4
e6/l
0.7
0.9
0.25
99
669
(40768446) Kidney Pathology biopsy report
17
60
2.69
3.36
4.1
2.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
25
3.78
3.35
4.2
3.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
319
2507
1.30
3.34
6.7
4.4
e6/l
30.2
45.2
0.87
224
1620
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
35
171
1.95
3.32
2.7
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
53
296
1.72
3.30
2.5
1.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
29
133
2.08
3.26
4.0
2.1
g/l
0.8
1.2
2.35
24
122
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
20
78
2.43
3.26
2.4
1.6
u/ml
0.9
0.5
—
10
15
(3021960) Folate [Moles/volume] in Serum or Plasma
108
717
1.47
3.25
1.6
1.3
nmol/l
24.3
19.0
3.27
100
629
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
173
1249
1.37
3.25
3.8
2.8
u/l
59.5
54.3
0.66
164
1157
(3030467) Casts [#/volume] in Urine by Automated count
252
1927
1.31
3.21
6.1
3.7
e6/l
0.2
0.2
0.53
205
1420
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
10
6.60
3.21
2.9
3.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
84
533
1.53
3.14
14.6
11.4
mmol/l
105.9
105.6
0.20
84
527
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
30
142
2.01
3.11
4.5
5.9
u/ml
12.1
24.1
0.54
30
122
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
136
2.03
3.09
14.1
26.6
u/ml
0.3
0.3
0.93
20
86
(3009261) Glucose [Presence] in Urine by Test strip
375
3034
1.27
3.06
4.1
3.2
estimate
0.0
0.0
0.00
62
574
(3042936) Bacteria identified in Isolate by Culture
100
662
1.47
3.06
2.4
1.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
111
750
1.44
3.05
6.8
3.5
g/l
8.9
9.3
0.69
106
716
(3007853) Bacteria identified in Skin by Aerobe culture
123
847
1.42
3.05
2.3
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
15
5.03
3.02
1.1
1.3
nmol/l
139.9
134.9
—
8
15
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
18
70
2.44
2.97
6.4
7.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
80
510
1.52
2.94
1.6
1.4
mu/l
396.6
322.5
0.81
73
450
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
6
8
7.06
2.92
4.0
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
95
629
1.46
2.91
1.3
1.3
iu/ml
144.8
154.7
0.07
29
205
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
43
2.86
2.89
2.0
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
253
1961
1.29
2.88
6.0
3.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
38
2.98
2.87
1.3
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
12
38
2.98
2.87
1.8
1.5
umol/l
17.4
17.6
0.05
12
38
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
5
5
9.41
2.86
4.8
4.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
370
3011
1.26
2.81
5.9
4.6
estimate
0.0
0.0
0.00
61
588
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
31
156
1.89
2.74
1.7
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
147
1063
1.35
2.72
7.2
4.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
110
761
1.40
2.67
12.6
7.0
umol/l
4.6
6.5
1.46
94
618
(1001926) Buprenorphine [Presence] in Urine by Screen method
51
734
0.63
2.66
2.2
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
31
159
1.86
2.60
2.1
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
368
3014
1.24
2.59
4.1
3.2
estimate
0.0
0.0
0.00
57
552
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
267
1.65
2.54
1.4
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
15
58
2.45
2.52
1.5
1.2
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
8
19
3.97
2.52
1.4
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
64
2.37
2.51
1.5
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
47
277
1.62
2.45
1.9
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
69
916
0.68
2.45
2.1
2.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
29
149
1.85
2.43
1.3
1.3
—
68.0
—
0
9
(3028300) Cannabinoids [Presence] in Urine
70
924
0.68
2.41
2.0
2.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
11
5.13
2.41
3.0
3.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
59
369
1.53
2.41
6.8
7.5
g/l
0.2
0.4
2.00
45
287
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
151
1117
1.32
2.41
5.1
4.2
mg/l
2.3
1.4
0.52
112
766
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
25
3.39
2.40
1.8
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
19
84
2.14
2.39
2.1
4.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
19
84
2.14
2.39
2.1
4.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
70
922
0.69
2.39
2.1
2.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
33
178
1.76
2.38
1.4
1.7
g/l
0.5
0.7
1.15
28
160
(3016879) Cocaine [Presence] in Urine
64
855
0.68
2.35
2.0
2.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
211
1636
1.27
2.35
4.0
3.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
159
1189
1.31
2.34
18.3
8.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
69
908
0.69
2.34
2.0
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
83
560
1.43
2.34
2.7
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
27
138
1.86
2.31
1.3
1.3
—
9.5
—
0
13
(3010503) CD19 cells [#/volume] in Blood
9
26
3.26
2.31
2.9
2.8
e9/l
0.3
0.3
—
9
26
(3009871) Measles virus Ab [Titer] in Serum
8
21
3.59
2.30
2.0
2.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
24
118
1.93
2.30
1.4
1.3
—
1.5
—
0
6
(3009542) Hematocrit [Volume Fraction] of Blood
787
7073
1.36
2.28
21.5
13.5
%
38.7
39.5
3.73
709
6336
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
108
766
1.36
2.28
3.0
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
12
4.71
2.27
10.8
10.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
85
580
1.41
2.25
2.9
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
56
2.36
2.21
2.5
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
23
114
1.91
2.17
1.4
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
69
457
1.45
2.16
2.8
1.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
13
4.34
2.14
2.3
2.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
28
3.03
2.14
1.2
2.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
18
3.66
2.11
2.9
2.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
7
18
3.66
2.11
3.1
2.3
%
11.0
12.1
—
7
18
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
199
2212
0.80
2.11
2.3
2.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
53
335
1.51
2.09
11.3
15.2
mmol/l
-0.7
0.0
0.65
43
271
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
34
193
1.68
2.08
1.1
1.1
u/ml
0.6
6.5
—
6
67
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
172
1.71
2.06
2.7
2.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
25
130
1.82
2.05
4.6
4.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
547
0.63
2.03
1.5
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
36
2.62
1.95
1.1
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
174
1348
1.26
1.94
18.5
9.1
ph
7.4
7.4
—
7
41
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
67
451
1.42
1.94
2.8
1.8
u/ml
261.6
166.0
1.46
41
220
(3034274) Bile acid [Moles/volume] in Serum --fasting
56
365
1.47
1.92
5.2
4.0
umol/l
10.4
9.0
0.26
48
302
(21494755) Public health laboratory ask at order entry panel
52
693
0.68
1.92
1.1
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
237
0.47
1.92
1.1
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
16
73
2.07
1.90
1.4
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
86
1.98
1.90
1.8
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
36
214
1.60
1.87
3.2
2.7
ml/min/173m2
86.8
96.2
—
9
59
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
173
1347
1.25
1.85
18.5
9.0
mmol/l
0.8
0.9
0.06
128
971
(3002179) Metamyelocytes/100 leukocytes in Blood
58
384
1.44
1.85
4.9
4.8
%
0.5
0.4
0.28
15
83
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
160
1237
1.26
1.82
17.8
8.6
mmol/l
24.0
24.1
0.16
160
1231
(3029937) Albumin [Presence] in Urine by Test strip
190
1498
1.24
1.82
4.0
3.2
estimate
0.0
0.0
0.80
62
567
(3022145) Colonoscopy Study observation
54
354
1.46
1.81
1.5
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
33
2.57
1.77
2.1
2.5
pg
30.4
31.9
—
9
33
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
33
2.57
1.77
1.6
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
61
412
1.41
1.76
6.0
5.4
%
1.1
0.6
0.52
20
111
(3030313) Adrenal Ab [Titer] in Serum
7
22
2.99
1.75
1.9
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
22
2.99
1.75
3.0
2.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
53
350
1.44
1.73
3.2
2.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
57
2.15
1.71
2.8
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
70
2.02
1.70
2.2
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
70
2.02
1.70
2.7
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
97
1.85
1.68
1.6
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
57
384
1.42
1.67
1.5
1.5
nmol/l
1101.9
1081.0
0.07
44
295
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
29
420
0.63
1.63
1.4
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
223
2392
0.83
1.62
2.3
2.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
46
2.25
1.61
1.0
1.1
miu/ml
1227.6
1579.8
0.40
11
46
(3019150) Specific gravity of Urine by Refractometry
169
1336
1.23
1.58
3.5
2.9
kg/l
1.0
1.0
0.23
40
252
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
79
1.91
1.57
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
79
1.91
1.57
1.4
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
39
248
1.49
1.55
1.7
1.7
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
38
241
1.50
1.53
13.8
17.7
%
95.7
95.0
0.29
38
241
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
139
1554
0.81
1.53
2.1
2.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
25
2.63
1.52
22.7
11.8
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
80
1.89
1.52
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
80
1.89
1.52
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
80
1.89
1.52
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
80
1.89
1.52
1.4
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
204
1.53
1.50
3.1
4.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
40
258
1.47
1.49
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
40
258
1.47
1.49
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
398
0.65
1.47
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
26
2.53
1.46
1.9
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
56
387
1.38
1.45
6.2
5.5
%
0.0
0.0
0.00
17
92
(3049233) Organic acids panel - Urine
11
49
2.12
1.41
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
269
0.58
1.40
1.1
2.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
27
2.44
1.39
2.3
1.6
—
67.0
—
0
5
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
43
2.19
1.39
3.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
43
2.19
1.39
3.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
43
2.19
1.39
3.5
1.7
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
38
2.23
1.38
1.2
1.8
—
875521.4
—
0
7
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
79
581
1.30
1.37
2.8
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
33
209
1.50
1.36
14.7
20.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
16
2.94
1.34
2.4
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
16
2.94
1.34
2.4
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
98
1.73
1.34
1.1
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
471
4112
1.15
1.34
5.4
3.7
e6/l
20.4
205.9
—
5
32
(3018677) aPTT in Platelet poor plasma by Coagulation assay
127
995
1.23
1.31
8.2
6.6
s
30.7
31.1
0.38
122
984
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
78
1.81
1.29
1.3
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
11
51
2.03
1.29
1.2
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
133
1051
1.22
1.27
1.7
1.8
mmol/l
1.4
1.2
1.60
122
964
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
17
2.76
1.26
2.4
1.6
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
23
2.45
1.26
1.0
1.2
—
—
—
0
0
(3032641) Amino acids panel - Urine
8
33
2.28
1.26
1.5
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
65
1.89
1.26
1.4
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
254
2645
0.86
1.26
1.9
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
171
1386
1.19
1.25
6.1
4.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
56
398
1.34
1.25
6.2
5.3
%
0.1
0.0
0.03
19
105
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
323
3303
0.87
1.24
2.0
1.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
19
108
1.66
1.23
1.1
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
50
617
0.74
1.23
1.4
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
23
138
1.58
1.22
3.2
1.7
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
19
109
1.65
1.20
1.1
1.3
%
87.6
73.7
0.76
19
109
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
18
2.61
1.19
1.4
1.3
nmol/l
4.1
1.8
—
5
18
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
21
124
1.60
1.19
1.2
1.5
u/ml
2.7
4.9
1.12
11
66
(4306422)
18
102
1.67
1.18
1.2
1.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
32
0.00
1.16
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
74
1.78
1.16
1.4
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
36
241
1.42
1.16
14.5
17.7
%
0.7
0.7
1.13
36
241
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
34
0.00
1.14
0.0
1.4
—
6.2
—
0
6
(3044889) 12 lead EKG panel
296
2524
1.15
1.14
2.3
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
36
242
1.41
1.13
1.2
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
37
2.03
1.13
4.6
1.5
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
16
89
1.70
1.13
3.6
3.9
%
0.2
2.4
—
5
36
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
19
2.47
1.12
1.8
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
33
427
0.71
1.11
3.0
2.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
104
814
1.22
1.10
2.4
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
97
1.65
1.10
1.6
1.8
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
132
0.49
1.10
1.6
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
118
1294
0.83
1.08
1.8
2.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
18
105
1.62
1.08
6.0
6.3
mmol/l
2.0
1.8
0.24
12
52
(3027315) Oxygen [Partial pressure] in Blood
18
105
1.62
1.08
6.0
5.9
kpa
10.1
9.4
0.73
18
105
(3013290) Carbon dioxide [Partial pressure] in Blood
18
105
1.62
1.08
6.0
6.3
kpa
5.3
4.8
2.71
18
105
(3020630) Protein [Mass/volume] in Serum or Plasma
32
213
1.42
1.07
3.7
3.9
g/l
63.2
64.3
0.27
32
206
(1616796) Gas panel - Central venous blood
21
128
1.55
1.06
4.9
4.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
131
1419
0.84
1.05
1.7
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
47
336
1.33
1.04
2.6
2.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
33
223
1.40
1.03
3.8
4.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
18
107
1.59
1.01
2.9
8.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
145
1.50
1.01
1.7
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
52
379
1.30
1.01
1.4
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
33
1.99
0.99
1.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
16
93
1.62
0.98
3.9
5.8
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
27
0.00
0.98
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
17
101
1.59
0.96
4.1
5.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
47
1.80
0.96
1.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
47
1.80
0.96
1.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
47
1.80
0.96
1.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
47
1.80
0.96
1.0
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
43
308
1.32
0.95
1.3
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
43
308
1.32
0.95
3.0
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
246
2096
1.14
0.94
3.7
2.9
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
35
1.88
0.92
1.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.17
0.92
5.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.17
0.92
5.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.17
0.92
5.0
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.17
0.92
5.0
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
95
1.59
0.92
1.3
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
88
1.61
0.90
1.3
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
52
1.81
0.89
1.2
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
214
1.37
0.88
2.5
2.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
74
1.65
0.87
1.1
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
94
750
1.19
0.85
1.3
1.2
iu/ml
30.0
13.2
0.68
16
170
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
128
1.47
0.84
1.2
1.5
u/ml
1.9
4.8
—
9
61
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
401
3974
0.90
0.84
3.6
2.5
mmol/l
1.2
1.1
0.92
387
3792
(3037467) Urinalysis macro (dipstick) panel - Urine
480
4283
1.11
0.80
6.3
4.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
37
268
1.31
0.79
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
69
1.64
0.79
1.1
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
14
84
1.57
0.78
1.8
1.2
u/l
11.2
9.5
0.14
14
75
(4268621)
14
84
1.57
0.78
2.0
2.8
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
17
107
1.50
0.78
1.2
1.2
%
118.3
103.9
0.51
17
101
(3035320) C reactive protein [Mass/volume] in Body fluid
13
77
1.59
0.77
1.5
1.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
16
100
1.51
0.76
2.6
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
460
4102
1.10
0.76
2.6
2.3
mmol/l
5.2
5.4
1.87
431
3772
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
49
1.73
0.76
1.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
49
1.73
0.76
1.0
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
88
707
1.18
0.76
1.3
1.2
u/ml
4.5
5.4
0.11
32
232
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
150
0.62
0.74
1.8
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
230
1.31
0.73
4.1
4.6
e6/l
635.0
17311.5
0.48
26
173
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
230
1.31
0.73
4.0
4.6
e6/l
9.4
15.1
0.35
26
168
(3008898) HLA-B27 [Presence]
32
385
0.77
0.72
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
86
1.53
0.72
1.4
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
12
71
1.59
0.72
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
53
1.60
0.71
1.3
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
426
4183
0.91
0.70
3.5
2.5
mmol/l
1.4
1.4
0.34
409
3975
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
109
898
1.16
0.70
1.1
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
7
110
0.59
0.68
1.3
1.4
—
296.0
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
52
403
1.22
0.67
1.3
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
26
1.81
0.66
3.4
1.7
—
—
—
0
0
(3015736) pH of Urine
272
2378
1.10
0.66
4.0
3.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
86
700
1.17
0.65
2.9
3.7
ng/l
802.2
1343.6
0.72
42
374
(3032080) INR in Blood by Coagulation assay
150
1270
1.13
0.65
5.0
4.2
inr
1.1
1.1
0.12
36
364
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
41
1.60
0.65
1.4
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
55
612
0.83
0.64
2.6
2.5
—
—
—
0
0
(4024509)
5
27
1.74
0.64
1.4
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
11
66
1.57
0.63
1.9
1.8
e6/l
6414.7
11584.1
—
6
46
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
47
1.60
0.61
1.3
1.2
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
19
0.00
0.60
0.0
1.0
—
165.7
—
0
19
(3050129) First trimester maternal screen panel - Serum or Plasma
90
742
1.15
0.59
1.5
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
44
495
0.82
0.59
1.5
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
32
1.76
0.58
1.3
1.2
nmol/l
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
8
50
1.50
0.58
5.5
3.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10
60
1.57
0.58
1.4
1.2
ug/l
0.5
0.5
—
5
15
(3006462) Nitrate [Presence] in Urine
6
33
1.71
0.57
4.7
2.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
20
247
0.75
0.57
1.3
1.5
u/ml
2.3
15.0
1.38
13
169
(3021788) Differential panel - Synovial fluid
8
51
1.47
0.57
1.3
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
108
1.39
0.55
1.4
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
35
1.61
0.55
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
199
2003
0.91
0.55
1.7
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
55
440
1.18
0.54
1.9
1.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
36
1.56
0.54
1.0
1.5
—
—
—
0
0
(4211845)
6
36
1.56
0.54
4.8
2.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
117
1.37
0.53
3.3
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
433
4214
0.93
0.53
3.5
2.6
mmol/l
2.7
2.7
0.30
417
3974
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
93
1.42
0.53
2.9
2.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
209
1827
1.09
0.52
6.2
4.7
u/l
29.9
32.9
1.11
199
1749
(3044640) Blood type and Crossmatch panel - Blood
215
1884
1.09
0.50
4.8
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
181
1576
1.09
0.49
3.3
2.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
14
95
1.39
0.48
3.4
3.4
ug/l
1.5
3.1
—
7
55
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
71
1.46
0.48
1.5
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
79
1.43
0.48
2.0
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
438
4249
0.93
0.48
3.7
2.6
mmol/l
4.4
4.4
0.01
423
4057
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
44
1.49
0.47
1.4
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
44
1.49
0.47
1.4
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
44
1.49
0.47
1.4
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
45
1.46
0.47
1.4
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
45
1.46
0.47
1.3
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
77
0.61
0.46
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
96
1.37
0.46
1.4
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
46
1.43
0.46
8.3
6.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
42
334
1.19
0.45
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
166
1446
1.09
0.45
4.9
4.6
mmol/l
6.7
8.4
4.53
151
1341
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
28
214
1.23
0.44
1.1
1.1
iu/ml
3.5
7.4
—
6
33
(3017732) Neutrophils [#/volume] in Blood
50
405
1.17
0.44
2.4
1.8
e9/l
4.5
4.3
0.29
43
372
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
427
3862
1.07
0.43
10.3
5.8
ml/min/173m2
112.9
109.5
2.20
310
2617
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
12
81
1.39
0.43
1.5
2.2
mg/l
10.3
8.8
0.69
12
75
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
22
256
0.80
0.43
1.4
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
30
1.56
0.42
1.0
2.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
30
1.56
0.42
1.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
18
131
1.29
0.42
6.5
4.9
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
103
881
1.11
0.41
2.0
1.5
titre
547.2
595.4
0.08
25
140
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
15
0.00
0.41
0.0
3.2
—
—
—
0
0
(3019225) pH of Specimen
32
251
1.20
0.41
4.3
4.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
27
208
1.22
0.41
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
131
1135
1.09
0.41
1.5
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.6
—
0.5
—
0
16
(3032773) Endomysium IgG Ab [Titer] in Serum
30
234
1.21
0.40
1.1
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
37
295
1.18
0.40
2.8
2.1
%
32.3
33.7
0.34
32
225
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
66
1.42
0.40
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
150
0.75
0.40
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
41
444
0.86
0.40
1.3
1.3
miu/ml
223.0
250.4
0.19
22
227
(3020682) Albumin/Creatinine [Ratio] in Urine
54
572
0.88
0.39
5.1
4.8
mg/mmol
42.3
38.1
0.04
44
454
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
33
1.42
0.39
1.2
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
13
91
1.34
0.39
1.2
1.4
nmol/l
24.9
34.1
0.87
13
83
(46235355) HIV 1 and 2 tests - Meaningful Use set
283
2769
0.94
0.39
2.2
2.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
190
0.78
0.38
1.1
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
34
1.38
0.38
1.2
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
10
68
1.38
0.35
1.0
1.0
—
—
—
0
0
(3020891) Body temperature
16
118
1.27
0.35
15.9
7.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
71
602
1.11
0.35
1.1
1.2
u/ml
5.1
5.9
0.22
54
451
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
81
0.69
0.33
6.5
1.5
%
13.0
12.8
—
6
81
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
176
1562
1.07
0.32
4.4
2.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
48
1.37
0.31
1.1
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
57
481
1.12
0.31
1.8
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
50
1.31
0.30
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
50
1.31
0.30
1.1
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
50
1.31
0.30
1.1
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
16
184
0.81
0.30
4.0
1.9
titre
84.0
60.0
—
5
17
(42529406) Shigella sp [Presence] in Stool by Culture
21
234
0.84
0.30
1.4
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
100
0.75
0.29
1.3
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
96
836
1.08
0.29
2.7
2.4
u/l
13894.4
7532.8
0.42
34
319
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
39
323
1.14
0.29
1.1
1.1
u/ml
1.4
0.3
0.36
19
142
(4027681)
10
71
1.32
0.28
1.2
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
20
157
1.20
0.27
2.3
2.2
u/ml
56.3
34.0
0.40
20
152
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
20
157
1.20
0.27
1.6
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
20
157
1.20
0.27
1.8
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
151
0.80
0.27
2.7
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
113
0.74
0.27
2.7
2.6
—
—
—
0
0
(1002224) Polysomnography panel
15
114
1.24
0.27
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
80
1.29
0.27
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
73
631
1.09
0.26
1.7
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
60
514
1.10
0.26
1.5
1.5
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
10
72
1.30
0.26
8.0
6.7
—
56.4
—
0
10
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
72
623
1.09
0.26
2.1
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
250
0.86
0.26
1.4
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
102
896
1.07
0.26
2.3
2.2
ng/l
15.5
65.2
1.01
32
295
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
63
641
0.91
0.25
1.6
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
265
1.14
0.24
5.2
3.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
53
542
0.91
0.24
4.9
3.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
90
1.25
0.24
1.2
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
73
1.29
0.24
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
10
73
1.29
0.24
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
228
0.86
0.23
1.4
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
24
195
1.16
0.23
1.4
1.2
iu/ml
13.4
223.2
—
5
72
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
160
1.17
0.23
3.8
2.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
36
1.30
0.23
1.2
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
22
178
1.16
0.23
8.7
7.9
%
54.0
57.3
0.25
22
173
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
37
1.27
0.22
2.4
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
37
1.27
0.22
1.2
1.1
—
—
—
0
0
(3013512) EKG study
79
692
1.08
0.22
2.2
2.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
167
0.84
0.22
1.8
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
38
1.23
0.22
1.2
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
20
161
1.17
0.22
1.6
1.7
u/ml
16.5
10.4
—
10
38
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
727
6743
1.05
0.22
17.5
10.1
mg/l
21.2
22.1
0.30
523
4744
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
39
1.20
0.21
4.2
5.5
ug/l
188.4
207.6
—
5
39
(3038702) Sodium [Moles/volume] in Capillary blood
0
10
0.00
0.21
0.0
3.1
—
139.6
—
0
10
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
144
1.17
0.21
5.5
3.8
%
47.9
51.9
0.66
18
144
(21491868) Cryoglobulin [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
45
1.25
0.20
1.2
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
10
75
1.25
0.20
9.1
8.5
mg/l
8.3
9.6
—
10
64
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
47
1.20
0.19
1.3
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
40
342
1.10
0.19
1.1
1.1
u/ml
9.0
10.4
0.16
31
205
(3011648) Oxygen content in Venous blood
15
119
1.18
0.19
29.3
26.1
%
11.6
11.7
0.04
15
119
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
93
1.21
0.19
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
64
562
1.07
0.18
1.8
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
32
272
1.11
0.17
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
221
0.89
0.17
1.4
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
260
0.90
0.17
1.1
1.6
mg/l
2.3
3.8
1.31
19
167
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
122
0.84
0.16
1.1
1.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
29
297
0.91
0.15
1.0
1.0
mu/l
9.8
8.4
0.29
24
251
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
140
1.14
0.15
4.1
3.6
e9/l
2.9
3.5
0.75
17
140
(40768804) Tissue Pathology biopsy report
166
1509
1.04
0.14
2.0
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
294
1.09
0.14
5.0
3.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
141
1.13
0.13
3.9
2.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
21
177
1.11
0.13
5.3
5.5
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
94
0.80
0.13
1.4
1.2
—
—
—
0
0
(4034850)
10
110
0.85
0.13
11.5
6.6
—
—
—
0
0
(3006598) pH of Arterial cord blood
22
227
0.91
0.13
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
66
589
1.05
0.12
1.1
1.2
u/ml
2.4
1.1
0.34
46
410
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
54
479
1.06
0.12
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
47
415
1.06
0.12
1.1
1.2
—
25.1
—
0
11
(3035933) Granulocytes/100 leukocytes in Blood
15
158
0.89
0.12
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
59
580
0.95
0.12
1.6
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
125
1.13
0.11
1.2
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
138
1257
1.03
0.11
1.8
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
381
3525
1.02
0.10
6.3
3.8
u/l
26.2
26.5
0.04
363
3387
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
41
1.14
0.10
1.2
1.2
nmol/l
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
42
1.12
0.10
1.6
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
42
1.12
0.10
1.0
1.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
42
1.12
0.10
1.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
43
1.09
0.09
1.6
2.8
umol/l
14.8
17.8
—
5
43
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
50
447
1.05
0.09
1.3
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
52
1.08
0.08
2.3
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
52
1.08
0.08
2.3
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
52
1.08
0.08
2.3
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
182
1.08
0.08
1.8
2.1
iu/l
2.0
4.4
—
8
69
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
6
55
1.02
0.08
1.0
1.2
—
58.8
—
0
10
(3016018) Differential panel - Cerebral spinal fluid
16
137
1.10
0.08
3.9
4.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
30
297
0.94
0.08
1.5
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
247
1.06
0.08
1.8
1.6
iu/ml
0.0
0.0
—
7
55
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
211
0.93
0.07
1.7
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
284
1.06
0.07
1.2
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
8
69
1.09
0.07
1.4
1.5
—
17.0
—
0
5
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
78
1.08
0.07
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
79
1.07
0.07
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
219
2079
0.98
0.07
2.1
1.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
9
82
1.03
0.07
11.0
4.0
mmol/l
1.5
1.7
—
9
82
(3014133) Dog dander IgE Ab [Units/volume] in Serum
41
368
1.05
0.07
1.1
1.1
u/ml
3.2
8.5
2.10
28
206
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
8
85
0.88
0.07
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
91
832
1.03
0.06
1.8
1.5
%
1.4
1.3
0.49
83
758
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
25
221
1.06
0.06
1.5
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
59
570
0.97
0.06
1.6
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
27
266
0.95
0.06
1.5
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
59
569
0.97
0.06
3.8
4.1
mg/l
429.1
121.3
0.57
49
447
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
59
569
0.97
0.06
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
59
569
0.97
0.06
1.6
1.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
64
583
1.03
0.05
1.1
1.2
u/ml
4.5
4.2
0.04
25
188
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
71
648
1.03
0.05
1.1
1.2
u/ml
2.2
2.7
0.15
46
416
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
233
2206
0.99
0.05
1.9
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
130
1.08
0.05
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
167
1.07
0.05
1.7
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
27
265
0.95
0.05
1.5
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
59
566
0.97
0.04
1.6
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
26
254
0.96
0.04
1.4
1.5
u/ml
9.9
3.3
0.94
19
183
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
128
1183
1.02
0.04
1.6
1.6
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
18
178
0.95
0.04
1.4
1.7
mmol/l
7.1
7.1
0.05
13
111
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
24
215
1.05
0.04
1.5
2.7
nmol/l
1.7
0.4
1.82
24
184
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
37
337
1.03
0.03
1.8
1.3
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
12
120
0.94
0.03
1.3
1.2
u/ml
0.3
14.6
2.99
12
111
(3024928) Oxygen saturation in Venous blood
20
180
1.04
0.02
26.0
18.6
—
—
—
0
0
(4198724)
12
118
0.95
0.00
2.2
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
290
2721
1.00
0.00
5.7
4.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
90
1.04
0.00
1.8
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
49
464
0.99
0.00
1.2
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
48
448
1.00
0.00
1.6
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
79
738
1.00
0.00
1.7
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
51
480
0.99
0.00
1.6
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
97
0.96
0.00
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
107
0.96
0.00
1.5
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
759
7105
1.00
0.00
4.2
4.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
11
108
0.95
0.00
1.1
1.0
g/l
1.4
1.4
0.10
11
100
(3005033) Fetal Nuchal fold Thickness US
48
445
1.01
0.00
1.6
1.5
—
—
—
0
0
(44813793)
13
118
1.03
0.00
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
48
454
0.99
0.00
1.7
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
48
0.98
0.00
1.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
61
0.92
0.00
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
6
61
0.92
0.00
1.0
1.1
u/ml
0.4
4.4
—
6
52
(1761482) Bacteria [#/volume] in Urine by Culture
6
62
0.91
0.00
3.3
2.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
50
0.94
0.00
4.4
2.4
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001488) Cow milk IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
50
0.94
0.00
8.8
4.8
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: E4_SHORT – Short stature, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).